Insights

Targeted discovery Icagen focuses on target-to-lead drug discovery with experience in ion channels, kinases, GPCRs and transporters, suggesting strong alignment with pharma and biotech partners seeking efficient target feasibility and lead generation.

Integrated programs Their model supports multi-year, integrated drug discovery programs as well as piecemeal projects, offering scalable collaboration options for companies at different R&D stages and budget needs.

North American bench strength A North American team with over 20 years of early discovery experience signals reliability, potential for fast collaboration, and access to established regulatory and industry networks.

Tech-enabled pipeline Use of computational chemistry, virtual screening and ultra-high throughput screening indicates a modern, tech-forward approach that can accelerate lead generation and reduce timelines for partners.

Growth and capability fit Moderate revenue and funding combined with a focused service model positions Icagen as a candidate for expansion partnerships, co-development deals, or strategic collaborations with mid-to-large CROs and pharma companies seeking niche discovery capabilities.

Similar companies to Icagen

Icagen Tech Stack

Icagen uses 8 technology products and services including HubSpot Analytics, Amazon Web Services, Cloudflare, and more. Explore Icagen's tech stack below.

Icagen's Email Address Formats

Icagen uses at least 4 email formats:
Icagen Email FormatsExamplePercentage
FLast@icagen.comJDoe@icagen.com
93%
FMiddleLast@icagen.comJMichaelDoe@icagen.com
4%
First.Last@icagen.comJohn.Doe@icagen.com
1%
LastFirst@icagen.comDoeJohn@icagen.com
2%

Frequently Asked Questions

What is Icagen's phone number?

Minus sign iconPlus sign icon
You can contact Icagen's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Icagen's stock symbol?

Minus sign iconPlus sign icon
Icagen is a publicly traded company; the company's stock symbol is SICAGEN.BO.

What is Icagen's official website and social media links?

Minus sign iconPlus sign icon
Icagen's official website is icagen.com and has social profiles on LinkedIn.

How much revenue does Icagen generate?

Minus sign iconPlus sign icon
As of July 2026, Icagen's annual revenue is estimated to be $1M - $10M.

What is Icagen's SIC code and NAICS code?

Minus sign iconPlus sign icon
Icagen's SIC code is 8733 - Noncommercial Research Organizations and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Icagen have currently?

Minus sign iconPlus sign icon
As of July 2026, Icagen has approximately 51 employees across 1 continents, including North America. Key team members include Chief Financial Officer: M. K., Principal Scientist: M. F. and Senior Scientist: S. Z. Explore Icagen's employee directory with LeadIQ.

What industry does Icagen belong to?

Minus sign iconPlus sign icon
Icagen operates in the Biotechnology industry.

What technology does Icagen use?

Minus sign iconPlus sign icon
Icagen's tech stack includes HubSpot Analytics, Amazon Web Services, Cloudflare, Open Graph, WordPress, MySQL, Font Awesome and Piwik.

What is Icagen's email format?

Minus sign iconPlus sign icon
Icagen's email format typically follows the pattern of FLast@icagen.com. Find more Icagen email formats with LeadIQ.

How much funding has Icagen raised to date?

Minus sign iconPlus sign icon
As of July 2026, Icagen has raised $21M in funding. The last funding round occurred on May 02, 2018 for $7.3M.
Icagen logo

Icagen

BiotechnologyNorth Carolina, United States51-200 Employees

Icagen is a midsize biotechnology research company based in Durham, North Carolina. It partners with global pharmaceutical and biotech companies to generate high-quality drug discovery leads, operating as a Target-to-Lead (T2L) provider. The organization works on multi-year integrated discovery programs as well as shorter, project-based efforts to fill gaps in R&D, drawing on a North American team with more than two decades of early-discovery experience.

Icagen begins with identifying druggable targets and assessing their feasibility in collaboration with partners. It conducts target-based discovery across a range of target families and advances selected targets through an iterative process that combines computational evaluation with screening, biology, and medicinal chemistry to develop viable leads.

Section iconCompany Overview

Phone number
Website
icagen.com
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
SICAGEN.BO
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Employees
51-200

Section iconFunding & Financials

  • $21M

    Icagen has raised a total of $21M of funding over 6 rounds. Their latest funding round was raised on May 02, 2018 in the amount of $7.3M as a Grant.

  • $1M - $10M

    Icagen's revenue is estimated to be in the range of $1M - $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.